WallachBeth Capital increased their price objective on shares of Globus Medical from $26 to $30, according to a Sleek Money report.
Here are four things to know about the company's stock:
• The company presently has an average rating of "buy" and a consensus target price of $28.24.
• Globus Medical has a 52-week low of $17.45 and a 52-week high of $27.14.
• The stock's 50-day moving average is $24.44 and its 200-day moving average is $22.
• The company has a market cap of $2.2 billion.
More articles on devices:
NuVasive's 2014 revenue up 11.3% — 10 key notes
Medtronic Spine to honor Dr. Kenneth Robinson
ChoiceSpine brings former Alphatec, TranS1 execs onboard — 5 things to know